Skip to content

To Study the Effect of Rasnadashmoolak Kashay and Vardhman Pippali Rasayan in Amavata.

A Randomized Controlled Trial Of Rasnadashmoolak Kashay Along With Vardhman Pippali Rasayan In Amavata wsrt Rheumatoid Arthritis. - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072489
Enrollment
90
Registered
2024-08-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Sponsors

Rushikesh Ravindra Khedkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with age group of 20 to 60 years of age will be included. Patients with more than or equal to 4 symptoms of Amavata like Sandhi Shoth, Sandhi Shool, Ushna Sparsha of Sandhi, Angamarda etc. will be included. ARA score more than or equal to 6 will be included. Disease Activity Score 28 more than 2.6 will be included. Patient of either sex or any religion or any educational field will be included. Patient who are willing to participate the study after written informed consent will be included.

Exclusion criteria

Exclusion criteria: Patient with age group less than 20 and more than 60 years will be excluded from the study. Chronicity of more than 10 years. Patients having Rheumatic Heart Fever, pulmonary tuberculosis, uncontrolled diabetes mellitus, chronic kidney disease will be excluded. Patient with serious life-threatening diseases will be excluded. Pregnant women and lactating mothers will be excluded.

Design outcomes

Primary

MeasureTime frame
To Compare The Efficacy Of Rasnadashmoolak Kashay Along With Vardhman Pippali Rasayan In Management Of Amavata w.s.r.t. Rheumatoid Arthritis with Symptoms Gradation Assessment Chart.Timepoint: On 0th day, On 11th day, On 16th Day

Secondary

MeasureTime frame
1] To Evaluate Clinical Efficacy Of Rasnadashmoolak Kashay Along With Vardhman Pippali Rasayan In Management Of Amavata w.s.r.t. Rheumatoid Arthritis With Disease Activity Score-28. 2] To Evaluate Clinical Efficacy Of Rasnadashmoolak Kashay Along With Vardhman Pippali Rasayan In Management Of Amavata w.s.r.t. Rheumatoid Arthritis With American Rheumatoid Arthrtis For Rheumatoid Arthritis.Timepoint: On 0th day, On 11th day, On 16th Day

Countries

India

Contacts

Public ContactDr Jayant Devidas Gulhane

Government Ayurveda College and Hospital, Nagpur

jayant.gulhane.62.6@gmail.com9822922399

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026